期刊文献+

215例经尿道前列腺汽化电切术治疗前列腺增生症 被引量:5

215 cases reports of treatments of BPH by transurethral vaporization of the prostate
下载PDF
导出
摘要 目的:探讨经尿道前列腺汽化电切术治疗良性前列腺增生(BPH)的疗效。方法:采用经尿道前列腺汽化切割并电切术(TUVP)治疗前列腺增生患者215例,年龄58~93岁,平均69.4岁,病程1个月~8年,术前IPSS评分平均为30.2分。结果:所有手术均取得成功,无一例转为开放手术,平均手术时间50min,术中无输血。术后随访1年以上67例,其中短暂尿失禁8例,经保守治疗后1个月内恢复。术后IPSS评分平均8.6分;平均最大尿流率(Qmax)18.8ml/s,较术前比较,差异均有统计学意义。结论:经尿道前列腺汽化切割并电切术治疗前列腺增生微创、安全、并发症少、疗效确切。 Objective:To investigate the curative effects of BPH by transurethral vaporization of the prostate.Methods:215 cases treatments of BPH were by transurethral vaporization of the prostate,the average of age was 69.4, the course of disease was from 1 month to 8 years. Preoperative international prostate symptom score was 30.2. Results:The curative effects were satisfactory, international prostate symptom score (IPSS) was 8.6, quantity of maximum urine (Qmax) was 18.8 ml/s, serious complications were not found. Conclusion:It was a safety,lower complications and effective treatment of BPH by transurethral vaporization of the prostate.
出处 《中国当代医药》 2009年第14期47-48,共2页 China Modern Medicine
  • 相关文献

参考文献5

二级参考文献20

  • 1郜苏英,宋群,李平,尚艳红.前列腺电切术病人体位对血流动力学影响及护理[J].中华护理杂志,1994,29(1):30-33. 被引量:55
  • 2[1]Holtgrewe HL.Tramurethral prostatectomy.Urol Clin North Am,1995,12(2):357-363.
  • 3[2]Puchner PJ.Miller MI.The effect of finasterid on hematuria associ ated with benign prostatic hyperplasia:a preliminary report.J Urol,1995.154:1779-1782.
  • 4[3]Shih SJ,Dall-Era MA,Westphal JR,et al.Elements regularing angiogenesis and correlative mierovessel density in benign hyper plastic and malignat prostate tissue.Prostate Cancer Prostatic Dis,2003.6:131-137.
  • 5[4]Baileyo DM,Foley SJ.Microvascular anatomy in patients with re current haematuria related to prostatic hypertrophy.J Urol,1999,161:865.
  • 6[5]Mc Connell JD,Bruskewitz R,Walsh PC,et al.The effect of finesteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia:fi nasteride long tertn efficacy and safety study group.N Engl J Med,1998,338(4):557-563.
  • 7[6]Foley SJ,Soloman Lz,Wedderbum AW,et al.A prospective atudy of the natural history of hematuria associated with benign prostatic hyperplasia and the effect of fimteride.J Urol,2000,163(2):496-498.
  • 8[7]Haggstrom S,Toning N,Moller K,et al.Effects of finasteride on vascular endothelial growth factor.ScandJ Urol Nephrol,2002,36(3):182-187.
  • 9Narayan P, Tewari A, Garzotto M, et al. Transurethral vaportrode electrovaporization of the prostates physical principles, technique, and results [J]. Urology, 1996, 47(4):505-511.
  • 10Desautel MG, Burney TL, Diaz DA, et al. Outcome of vaportrode transurethral vaporization of the prostate using pressure-flow urodynamic criteria [J]. Urology, 1998, 51(6):1013-1021.

共引文献11

同被引文献22

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部